Trial intelligence / Profile preview

Topical Tranexamic Acid and Sucralfate for Post-Sphincterotomy Bleeding

NCT06107504Recruiting

Sponsor
National Cheng Kung University Hospital
Start
Jan 2024
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sucralfate and tranexamic acid (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: The incident rate of delayed post-ERCP bleeding during the study period at 14 days. Started Jan 2024; status: recruiting.

02

Drugs

sucralfatetranexamic acid

Beyond the preview

Go deeper on NCT06107504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06107504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call